| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP2084134A1 Chemical compounds |
| 08/05/2009 | EP2084133A2 Process for preparing crystalline aripiprazole |
| 08/05/2009 | EP2083821A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 08/05/2009 | EP2083819A2 Pde10 inhibitors and related compositions and methods |
| 08/05/2009 | EP1713803B1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | EP1186594B1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 08/05/2009 | CN101501000A Purification process of Montelukast and its amine salts |
| 08/05/2009 | CN101499517A Organic light emitting diode and method of manufacturing the same |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/04/2009 | US7569584 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 08/04/2009 | US7569563 antiviral agents, in particular against cytomegaloviruses; Ethyl{(2RS,6SR)-4-[3-{[(2,4-dichlorobenzyl)amino]carbonyl}-6-fluoro-8-methoxy-4-oxo-1-(2,2,2-trifluoroethyl)-1,4-dihydroquinolin-7-yl]-2,6-dimethylpiperazin-1-yl}ethanoate hydroformate |
| 08/04/2009 | CA2334727C Tetrahydroquinoline derivatives as glycine antagonists |
| 07/30/2009 | WO2009073550A3 Substituted tetrahydroquinolines as antibacterial agents |
| 07/30/2009 | US20090192190 Benzoic Acid Derivatives that are Modulators or Agonists of GlyR |
| 07/30/2009 | US20090192148 Organic Compounds |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/30/2009 | US20090189518 Fused polycyclic compounds and organic light-emitting device using the same |
| 07/29/2009 | EP2081907A1 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders |
| 07/29/2009 | EP2081906A1 Sitamaquine tosylate for the treatment of leishmaniasis |
| 07/29/2009 | EP2081905A2 Sulfonyl compounds which modulate the cb2 receptor |
| 07/29/2009 | EP2081904A1 Aripiprazole hemifumarate and process for its preparation |
| 07/29/2009 | EP2081891A2 Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
| 07/29/2009 | EP1667974B1 Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative |
| 07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
| 07/29/2009 | CN101492419A Ambroxol salt |
| 07/29/2009 | CN100519533C 5-arylamino quinolyl-7,8-dione derivative and its application in preparing antibiotic medicine |
| 07/28/2009 | US7566786 enzyme inhibitor 4-[(3-methylphenyl)amino]-6-(methylsulfonyl)-3-quinolinecarboxamide; antiinflammatory agents for treatment, prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis |
| 07/28/2009 | US7566785 Amidine substituted aryl aniline compounds |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/28/2009 | US7566710 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 07/28/2009 | CA2437954C Process for producing quinolinecarboxyaldehyde derivative and intermediate |
| 07/23/2009 | WO2009091324A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | WO2009063070A3 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 07/23/2009 | WO2009047568A3 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
| 07/23/2009 | WO2008144865A3 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof |
| 07/23/2009 | WO2008076427A3 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | CA2711912A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | CA2701492A1 Methods of inhibiting viral infection |
| 07/22/2009 | EP2079723A2 Process for preparing anhydrous aripirazole type i |
| 07/22/2009 | EP2079699A1 Quinoline derivatives |
| 07/22/2009 | EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 07/22/2009 | CN101490005A Process for the purification of montelukast |
| 07/22/2009 | CN100516046C Synthesizing process of quinolone main cycle compound |
| 07/21/2009 | US7563807 Removal of aldehyde impurity by reactive polystyrene resini |
| 07/21/2009 | US7563806 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament |
| 07/21/2009 | US7563805 Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 07/16/2009 | WO2009089537A2 Anti-cancer compounds |
| 07/16/2009 | WO2009089083A1 Trpa1 antagonists |
| 07/16/2009 | WO2009087684A2 Novel tetrahydroquinolines as aromatase inhibitors |
| 07/16/2009 | WO2009087649A1 Renin inhibitors |
| 07/16/2009 | WO2009087098A2 Quinoline derivatives and their use as fungicides |
| 07/16/2009 | US20090182148 Process for the manufacture of montelukast sodium |
| 07/16/2009 | US20090182010 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 07/16/2009 | US20090182008 Crystalline forms of pitavastatin calcium |
| 07/16/2009 | US20090181971 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | CA2711159A1 Trpa1 antagonists |
| 07/16/2009 | CA2711094A1 Fungicides |
| 07/15/2009 | EP2077996A1 Purification process of montelukast and its amine salts |
| 07/15/2009 | CN101481350A Process for synthesizing norfloxacin |
| 07/14/2009 | US7560559 new crystalline form; prepared from acetonitrile monosolvate; active pharmaceutical ingredient of SINGULAIR (reg), and for the treatment of asthma and allergic rhinitis |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560557 Such as laquinimod by reacting a quinoline-3-carboxylic acid ester with an aniline derivative in a solvent of (cyclo)alkanes of given boiling point range; use of said solvent improves the yield and impurity profile |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/09/2009 | WO2008147797A3 Ion channel modulators and methods of use |
| 07/09/2009 | US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism |
| 07/09/2009 | US20090176987 Crystal form of quinoline compound and process for its production |
| 07/09/2009 | US20090176829 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/09/2009 | US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 07/09/2009 | US20090176774 Compounds and methods of use |
| 07/09/2009 | US20090176745 Triarylmethane analogs and their use in treating cancers |
| 07/09/2009 | US20090176270 Asymmetric cyanine fluorescent dyes, compositions and their use in staining biological samples |
| 07/08/2009 | EP2076495A1 Quinoline derivatives with 5-ht-binding properties |
| 07/08/2009 | CN101479246A Amino-ethyl-amino-aryl (AEAA) compounds and their use |
| 07/08/2009 | CN101479245A Quinolinone derivatives and their pharmaceutical compositions |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101475528A Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100510098C Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters |
| 07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |
| 07/08/2009 | CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 07/08/2009 | CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/07/2009 | US7557213 Such as 3-(Pyridine-4-carbonyl)-1-pyridin-2-ylmethyl-H-quinolin-4-one for treatment of cancer |
| 07/07/2009 | US7557125 Fab I inhibitors |
| 07/07/2009 | CA2539969C Process for the preparation of carboxylic acids of nitrogen-containing aromatic heterocyclic compounds |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/02/2009 | WO2009082346A1 New acetyl coenzyme a carboxylase (acc) inhibitors and uses in treatments of obesity and diabetes mellitus - 087 |
| 07/02/2009 | WO2009081956A1 Method for producing conjugated aromatic compound |
| 07/02/2009 | WO2009081483A1 Oxime esters and photopolymerization initiators containing the same |
| 07/02/2009 | WO2009080200A1 Novel sulphoximide-substituted quinoline and quinazoline derivatives as kinase inhibitors |